These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2435716)
1. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides. Fukuta S; Werkmeister JA; Burns GF; Ginsburg V; Magnani JL J Biol Chem; 1987 Apr; 262(10):4800-3. PubMed ID: 2435716 [TBL] [Abstract][Full Text] [Related]
2. Production of monoclonal antibodies specific for ganglioside GD3. Watarai S; Onuma M; Yasuda T J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444 [TBL] [Abstract][Full Text] [Related]
3. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3. Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209 [TBL] [Abstract][Full Text] [Related]
4. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845 [TBL] [Abstract][Full Text] [Related]
5. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468 [TBL] [Abstract][Full Text] [Related]
6. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2. Tai T; Kawashima I; Tada N; Dairiki K J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507 [TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells. Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889 [TBL] [Abstract][Full Text] [Related]
8. GD3 expression by cultured human tumor cells of neuroectodermal origin. He X; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD Acta Neuropathol; 1989; 79(3):317-25. PubMed ID: 2609939 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of gangliosides from Trypanosoma brucei. Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H J Parasitol; 2004 Feb; 90(1):123-7. PubMed ID: 15040678 [TBL] [Abstract][Full Text] [Related]
10. Identification of a structure on human melanoma cells recognized by CTL exhibiting anomalous killer cell function. Werkmeister JA; Triglia T; Andrews P; Burns GF J Immunol; 1985 Jul; 135(1):689-95. PubMed ID: 3873498 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy. Brindel I; Preud'homme JL; Vallat JM; Vincent D; Vasquez JL; Jauberteau MO Neurosci Lett; 1994 Nov; 181(1-2):103-6. PubMed ID: 7534889 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas. Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076 [TBL] [Abstract][Full Text] [Related]
13. Cell surface reactive human monoclonal antibody directed to human melanoma-associated gangliosides. Abdel-Wahab Z; Li WP; Darrow T; Nudelman ED; Towell A; Seigler HF Melanoma Res; 1993 Dec; 3(6):415-23. PubMed ID: 8161881 [TBL] [Abstract][Full Text] [Related]
14. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside. Brodin T; Hellström I; Hellström KE; Karlsson KA; Sjögren HO; Strömberg N; Thurin J Biochim Biophys Acta; 1985 Dec; 837(3):349-53. PubMed ID: 3840699 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. Nudelman E; Hakomori S; Kannagi R; Levery S; Yeh MY; Hellström KE; Hellström I J Biol Chem; 1982 Nov; 257(21):12752-6. PubMed ID: 7130176 [TBL] [Abstract][Full Text] [Related]
16. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas. Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252 [TBL] [Abstract][Full Text] [Related]
17. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma. Hirabayashi Y; Hamaoka A; Matsumoto M; Matsubara T; Tagawa M; Wakabayashi S; Taniguchi M J Biol Chem; 1985 Oct; 260(24):13328-33. PubMed ID: 2414279 [TBL] [Abstract][Full Text] [Related]
18. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies. Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157 [TBL] [Abstract][Full Text] [Related]
19. Antibody responses to ganglio-series gangliosides in different strains of inbred mice. Kawashima I; Nakamura O; Tai T Mol Immunol; 1992 May; 29(5):625-32. PubMed ID: 1584231 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative. Dubois C; Manuguerra JC; Hauttecoeur B; Maze J J Biol Chem; 1990 Feb; 265(5):2797-803. PubMed ID: 2303428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]